News
Milestone as EMA starts review of Atara's 'off-the-shelf' ce...
Atara Biotherapeutics' tabelecleucel (tab-cel) has become the first 'allogeneic' cell therapy – in other words one which doesn't involve harvesting cells from patients – to be evaluated by
